Sardesai; Niranjan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sardesai; Niranjan.The latest application filed is for "dna antibody constructs and method of using same".

Company Profile

6.14.20

Sardesai; Niranjan - Blue Bell PA
Sardesai; Niranjan - North Wales PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
DNA Antibody Constructs And Method Of Using Same App 20220112273 - Weiner; David ; et al.	2022-04-14
DNA antibody constructs and method of using same Grant 11,278,619 - Weiner , et al. March 22, 2	2022-03-22
Checkpoint Inhibitor and Vaccine Combinations and Use of Same for Immunotherapy App 20210401978 - Weiner; David ; et al.	2021-12-30
DNA antibody constructs and method of using same Grant 11,208,470 - Weiner , et al. December 28, 2	2021-12-28
Checkpoint inhibitor and vaccine combinations and use of same for immunotherapy Grant 11,116,838 - Weiner , et al. September 14, 2	2021-09-14
Pd1 And Pdl1 Antibodies And Vaccine Combinations And Use Of Same For Immunotherapy App 20210085779 - WEINER; David ; et al.	2021-03-25
PD1 and PDL1 antibodies and vaccine combinations and use of same for immunotherapy Grant 10,835,595 - Weiner , et al. November 17, 2	2020-11-17
DNA Monoclonal Antibodies Targeting Checkpoint Molecules App 20190142920 - Weiner; David B. ; et al.	2019-05-16
Dna Antibody Constructs And Method Of Using Same App 20190091322 - Weiner; David B. ; et al.	2019-03-28
DNA Antibody Constructs And Method Of Using Same App 20190085058 - Weiner; David ; et al.	2019-03-21
Dna Antibody Constructs And Method Of Using Same App 20180346554 - Weiner; David B. ; et al.	2018-12-06
Novel Vaccines Against Multiple Subtypes Of Dengue Virus App 20180326037 - Weiner; David B. ; et al.	2018-11-15
DNA antibody constructs and method of using same Grant 10,087,240 - Weiner , et al. October 2, 2	2018-10-02
Compositions and methods for generating a synthetic antibody Grant 9,994,629 - Weiner , et al. June 12, 2	2018-06-12
Vaccines against multiple subtypes of dengue virus Grant 9,987,347 - Weiner , et al. June 5, 2	2018-06-05
Checkpoint Inhibitor and Vaccine Combinations and Use of Same For Immunotherapy App 20180015161 - Weiner; David ; et al.	2018-01-18
Dna Antibody Constructs And Method Of Using Same App 20170266282 - Weiner; David B. ; et al.	2017-09-21
Pd1 And Pdl1 Antibodies And Vaccine Combinations And Use Of Same For Immunotherapy App 20170007693 - WEINER; David ; et al.	2017-01-12
DNA Antibody Constructs And Method Of Using Same App 20160311891 - Weiner; David ; et al.	2016-10-27
Cross-protective arenavirus vaccines and their method of use Grant 9,446,114 - Broderick , et al. September 20, 2	2016-09-20
Novel Vaccines Against Multiple Subtypes Of Dengue Virus App 20160022802 - Weiner; David B. ; et al.	2016-01-28
Dna Antibody Constructs And Method Of Using Same App 20150284448 - Weiner; David B. ; et al.	2015-10-08
Vaccines against multiple subtypes of dengue virus Grant 8,835,620 - Ramanathan , et al. September 16, 2	2014-09-16
Detection of mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of the peritoneum and the peritoneal cavity App 20060014211 - O'Shannessy; Daniel J. ; et al.	2006-01-19
Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of mesothelioma App 20060014221 - O'Shannessy; Daniel J. ; et al.	2006-01-19

Company Registrations

SEC

0001464547

Sardesai Niranjan

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.